Status:

COMPLETED

The Effect of Acceptance and Commitment Therapy

Lead Sponsor:

S.Anna Rehabilitation Institute

Collaborating Sponsors:

Istituto per la Ricerca e l'Innovazione Biomedica

Conditions:

Autism, Infantile

Eligibility:

All Genders

3-13 years

Phase:

NA

Brief Summary

In this randomized control study, investigators will evaluate the effectiveness of the Acceptance and Commitment Therapy (ACT) matrix behavioral protocol compared to Parent Training (PT) programs in i...

Detailed Description

Autism Spectrum Disorder (ASD) is a lifelong neurodevelopmental disorder characterized by core deficits in maladaptive behaviors, communication skills, and self-regulation im-pairments affecting the s...

Eligibility Criteria

Inclusion

  • The families were recruited as part of an ongoing research program and tested at our clinical facilities.
  • Inclusion criteria were based on children characteristics as follows:
  • between 3 and 13 years of age;
  • clinical diagnosis of ASD based on the DSM-5 criteria from a licensed clinical child neuropsychiatrist;
  • DSM-5 severity scores from mild (level 1) to moderate (level 2) in both social communication and restricted interests and repetitive behaviors domains;
  • a verbal and performance Developmental Quotient: Griffiths Mental Development Scales, Extended Revised: 2 to 8 years (GMDS-ER 2-8 Luiz et al. 2006) and Wechsler Intelligence Scale for Children (WISC-IV Wechsler D. 2003) above 70;
  • no hearing, visual, or physical disabilities that would prevent participation in the intervention;
  • not being on psychiatric medication. All children have a previous diagnosis that was further confirmed through the assessment and the consensus of experienced professionals on the research team (i.e., a child neuropsychiatrist and a clinical psychologist).

Exclusion

    Key Trial Info

    Start Date :

    January 7 2018

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    December 30 2020

    Estimated Enrollment :

    66 Patients enrolled

    Trial Details

    Trial ID

    NCT04909658

    Start Date

    January 7 2018

    End Date

    December 30 2020

    Last Update

    June 2 2021

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Institute for Biomedical Research and Innovation (IRIB)

    Messina, Italy, 98164